Port Capital’s Utah Medical Products UTMD Stock Holding History

Port Capital’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-18,064	Closed	-$1.95M	–	93
2019 Q4	$1.95M	Hold	18,064	–	–	0.22%	46
2019 Q3	$1.73M	Hold	18,064	–	–	0.2%	53
2019 Q2	$1.73M	Buy	18,064 +1,100	+6%	+$92.6K	0.2%	52
2019 Q1	$1.5M	Buy	16,964 +8,125	+92%	+$714K	0.2%	55
2018 Q4	$734K	Buy	8,839 +3,284	+59%	+$289K	0.11%	73
2018 Q3	$523K	Buy	+5,555	New	+$531K	0.06%	107

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Port Capital's UTMD Position: Q1 2020 in Review

Port Capital sold out of Utah Medical Products (UTMD) in Q1 2020, closing a stake of 18,064 shares — an estimated $1.95M sold.

Port Capital first reported a position in UTMD in Q3 2018 and held it in 6 quarters. The position peaked at $1.95M in Q4 2019. 90 funds tracked by Wall St. Rank hold UTMD as of Q1 2020.

Port Capital reported no remaining Utah Medical Products position as of Q1 2020 after selling out during the quarter.
Port Capital sold 18,064 Utah Medical Products shares in Q1 2020, an estimated $1.95M.
Port Capital first reported a position in Utah Medical Products in Q3 2018 and held it in 6 quarters.
Port Capital's Utah Medical Products position peaked at $1.95M in Q4 2019.
90 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2020.

Based on Port Capital's 13F filing for Q1 2020, filed 15 May 2020.